Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to test if our Community Health Worker program can help at-risk NYC Chinese community members participate in shared decision making and lung cancer screening (if appropriate) and compare it to the help provided by written materials.


Clinical Trial Description

The study first used qualitative methods to inform the adaptation of a CHW model to facilitate lung cancer screening completion in an extremely high-risk group, NYC Chinese livery drivers who smoke or who quit within the past 15 years. A series of focus groups with Chinese livery drivers who smoke, a series of in-depth interviews with livery base management and staff, primary care physicians (PCPs), clinic directors, hospital CFOs, heads of financial services and counseling, and heads of radiology facilities serving the Chinese community were conducted to explore barriers and factors related to cancer screening. Findings were used to develop adapted intervention materials, including a CHW Manual for Facilitating Shared Decision Making and Lung Cancer Screening. Once adaptation is complete, the researchers will conduct a pre-pilot to refine the adapted CHW intervention materials. The researchers will then conduct a pilot randomized controlled trial (RCT) to assess the feasibility of the refined CHW model (intervention) versus written materials (control) to facilitate SDM and LCS (when appropriate) in an extremely high-risk group, NYC Chinese livery drivers eligible (by USPTSF criteria) for LCS. Feasibility results will be used to inform the planning and design of large scale RCTs, targeting Chinese drivers, as well as other driver populations in NYC and throughout the U.S., and other high risk Chinese smoking populations in other occupations (e.g. restaurant work, construction). The study is currently in the pre-pilot phase and expects to launch the pilot phase by the summer of 2020. Due to the effects of the COVID-19 crisis, the researchers have extended the pre-pilot participation time frame to 12 months. The study population has also indicated concern to attend doctor's appointments for SDM/LCS during COVID-19. As such, MSK is extending the study time frame to an additional 6 months. . CHWs will also be hosting health education workshops at community organizations, family associations, and public libraries. These workshops will be conducted in English, Mandarin, and Cantonese and cover topics including smoking cessation and lung cancer screening. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02914899
Study type Interventional
Source Memorial Sloan Kettering Cancer Center
Contact
Status Active, not recruiting
Phase Early Phase 1
Start date August 2016
Completion date May 2024

See also
  Status Clinical Trial Phase
Completed NCT02944903 - Audit of Lung Cancer Screening Practice in Chest Physicians: An Update N/A
Recruiting NCT02292485 - PCORI-CER-1306-03385 Lung Cancer Screening Readiness Study
Active, not recruiting NCT05630950 - LDCT-SC-FI Low-dose CT Screening for Lung Cancer N/A
Completed NCT03200236 - The Lung Screening, Tobacco and Health Project Phase 3
Recruiting NCT03853967 - Lung Cancer Screening by Low Dose CT Scan in a French Department (DEP KP80) N/A
Recruiting NCT05645731 - Lung Cancer Screening in Family Members and Peers of Lung Cancer Patients: a Prospective Cohort Study
Active, not recruiting NCT05920850 - The SHARED, Project, Lung Cancer Screening for African American Men (AAM) N/A
Active, not recruiting NCT03069924 - Gain-framed Messages and NRT for Lung Cancer Screening Patients Phase 2
Completed NCT02899754 - Lung Cancer Screening Decisions N/A
Completed NCT03793894 - Inpatient Smokers and LDCT Screening Part 2 N/A
Active, not recruiting NCT04691297 - Digitally Enhanced Smoking Cessation for High Risk Smokers N/A
Enrolling by invitation NCT05747443 - Multilevel Interventions to Increase Adherence to Lung Cancer Screening N/A
Recruiting NCT05195385 - Lung Cancer Screening With Low-dose CT Scan in Women : Implementation Study N/A
Completed NCT03958253 - Lung Cancer Screening Protocol N/A